In 2023, the global Biomaterial Market is anticipated to be valued at USD 1,72,689.3 million. By 2033, it is anticipated to be worth USD 3,86,983.6 million. From 2023 to 2033, the biodegradable Biomaterial Market expects growth at a striking 8.4%.
Key Market Drivers
The primary factors boosting the global Biomaterial Market growth are an increase in government grants and financing for the creation of innovative biomaterials, a rise in the demand for medical implants, an increase in the prevalence of cardiovascular illnesses, and an expansion of regenerative medicine biomaterials research. Applications in wound healing and plastic surgery are expected to surge significantly in the following years, fueling growth in the medical biomaterials industry.
Creating intelligent biomaterials that communicate with biological systems for various biomedical uses, such as the transfer of bioactive substances and the cellular function of newly developed functional tissues, generates biodegradable Biomaterial Market revenue. Businesses' adoption of ongoing improvements in novel drug delivery strategies for the controlled release of drugs has increased demand for medical implants.
The rising frequency of musculoskeletal and chronic skeletal medical problems is predicted to raise demand for medical implants, which may fuel market expansion. Another reason boosting demand for orthopedic implants and speeding up the adoption of biomaterials is the expanding senior population, who are more likely to experience osteoarthritis, osteoporosis, and other musculoskeletal issues.
| Attributes | Details |
|---|---|
| Biomaterials Industry Value for 2023 | USD 1,72,689.3 million |
| Biomaterials Industry Value for 2033 | USD 3,86,983.6 million |
| Biomaterials Industry CAGR from 2023 to 2033 | 8.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Three phases of biomaterials innovation have occurred, each driven by different societal demands and catalysts. Wood, paper, leather, textiles, adhesives, soaps, and pigments were all part of the first wave of bio-based materials, predating the petroleum era, made from plants and animals.
Due to the development of biotechnology and recombinant DNA technologies, the second wave began to emerge in the 1980s. Companies like Genencor and the industrial enzyme business flourished at this time, transforming everything from laundry detergent to animal feed. The high cost of fossil-based feedstocks forced investments in cleantech and biofuels, which presented difficulties.
Rapid developments in DNA sequencing, gene editing, AI, and innovation focused on sustainability are characteristics of the current third wave. Nowadays, unlike in the past, competitiveness in the chemicals and materials industry is driven by sustainability. Global consumer demand for environmentally friendly products is rising, and regulators prioritize lowering CO2 emissions and plastic litter. ESG fund investors compel businesses to reduce their carbon footprint and embrace development prospects.
Under pressure from customers, authorities, and investors, businesses are making commitments to environmental responsibility that impact their purchasing and production choices. The value proposition of sustainable products is being redefined by this seismic change, which is also accelerating the third wave of biomaterials innovation.
Increased applications in healthcare, tissue engineering, and regenerative medicine biomaterials propelled the biodegradable Biomaterial Market expansion from 2018 to 2022. Developments in biocompatible materials trends such as synthetic polymers and bioactive ceramics facilitated growth in the Biomaterial Market.
| Historical CAGR | 13.3% |
|---|---|
| Forecast CAGR | 8.4% |
The biomaterials industry is anticipated to experience even more significant growth from 2023 to 2033. Predictions in 3D printing, personalized medicine, and drug delivery systems include a rise in demand for biomaterials. Concerns over sustainability and a move toward eco-friendly biomaterials are likely to have an impact on the market. To stimulate innovation and meet new difficulties, collaboration between the biotechnology, materials science, and healthcare industries becomes essential in determining the future of biomaterials.
Principal Consultant
The rise of chronic musculoskeletal and skeletal medical disorders contributes to the market. Advanced biomaterials must be developed and used for surgical implants and tissue regeneration biomaterials as the population ages and diseases like osteoarthritis, osteoporosis, and others become more common.
The rise significantly influences this trend in the population of older people. Many medical procedures performed on elderly patients, such as joint replacements, spinal implants, and dental prostheses, depend on cutting-edge biomaterials to improve patient outcomes and quality of life.
These changes in the population's demographics highlight the importance of ongoing research and innovation in the biomaterials industry, which is poised to fuel the growth in the Biomaterial Market by meeting the healthcare needs of an aging and increasingly ill population.
The increasing need for implantable biomaterials for medical devices reflects a greater reliance on cutting-edge healthcare solutions. These innovations, including prosthetic limbs to implanted organ supports and medicine delivery systems, are crucial for raising patient quality of life and advancing medical progress. The demand for medical implants is fueled by people looking for long-term approaches to managing their health due to the aging population and the prevalence of chronic diseases.
With its precise monitoring and tailored therapy, implantable devices can be used for diagnostic and therapeutic purposes. For delicate applications, in particular, their ability to remain in the body helps to maintain a stable environment.
The rising demand for implanted devices is an essential factor in the market's rise. The biomedical business's growth is fueled by the demand for biocompatible materials trends that ensure compatibility and longevity in the human body. Soon, the implanted devices market is expected to experience rapid expansion.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The strict clinical and regulatory procedures that control the efficiency and effectiveness of devices made of biomaterials pose difficulties for the medical biomaterials industry. This is especially important because many of these devices are made to be implanted inside of people. Potential investors are hesitant due to the stringent examination and testing necessary before these biomaterial products can be licensed commercially. Although the rigorous regulatory environment guarantees patient safety and device dependability, it also increases the time and resources required for market entrance.
Members' circumspection may hamper the market expansion of biomaterial. Despite these obstacles, prioritizing safety and efficacy is essential to assuring the creation of high-quality biomaterials for medical devices that eventually help patients and healthcare systems.
Due to its adaptability and variety of uses, the polymer product category has been at the forefront of the demand for biomaterials. The adoption of biomaterials and tissue engineering, drug delivery systems, medical implants, and other applications is rising. Biomaterials can be produced from natural sources or manufactured to resemble biological materials.
| Segment | Ceramic Biomaterials |
|---|---|
| Market Share | 18.5% |
| F-CAGR | 6.8% |
| Segment | Polymer Biomaterials |
|---|---|
| Market Share | 33.5% |
| F-CAGR | 6.3% |
| Segment | Metallic Biomaterials |
|---|---|
| Market Share | 27.6% |
| F-CAGR | 11.0% |
| Segment | Natural Materials |
|---|---|
| Market Share | 15.9% |
| F-CAGR | 10.4% |
| Segment | Other Materials |
|---|---|
| Market Share | 4.5% |
| F-CAGR | 6.7% |
The adjustable qualities of polymers, including biodegradability, mechanical strength, and compatibility with biological systems, are their unique selling point. Their supremacy in creating biomaterials, which addresses crucial requirements in healthcare, sustainable packaging, and other areas, has been fueled by this. Polymer-based biomaterials are at the forefront of the field's ongoing innovation, thrusting developments across numerous industries.
In its application area, the cardiovascular sector of the market has presented itself as the dominant contender. This popularity is brought about by increased demand for biomaterials used in various cardiovascular treatments, including vascular grafts, heart valve replacements, and stent implantation. The likelihood of rejection and problems is decreased by these materials' compatibility with the human body.
| Segment | Cardiology |
|---|---|
| Market Share | 21.1% |
| F-CAGR | 9.0% |
| Segment | Ophthalmology |
|---|---|
| Market Share | 8.2% |
| F-CAGR | 6.8% |
| Segment | Dental |
|---|---|
| Market Share | 16.4% |
| F-CAGR | 6.8% |
| Segment | Neurology |
|---|---|
| Market Share | 12.0% |
| F-CAGR | 9.5% |
| Segment | Orthopaedic |
|---|---|
| Market Share | 18.3% |
| F-CAGR | 6.9% |
| Segment | Respiratory |
|---|---|
| Market Share | 2.0% |
| F-CAGR | 6.8% |
| Segment | Wound Management |
|---|---|
| Market Share | 10.0% |
| F-CAGR | 8.3% |
| Segment | Aesthetic & Plastic Surgery |
|---|---|
| Market Share | 2.8% |
| F-CAGR | 9.7% |
| Segment | Tissue Engineering & Regenerative Medicine |
|---|---|
| Market Share | 7.2% |
| F-CAGR | 14.0% |
| Segment | Other Applications |
|---|---|
| Market Share | 2.1% |
| F-CAGR | 9.9% |
This leadership has been spurred by improvements in biomaterial technology and the increased prevalence of cardiovascular illnesses worldwide. Due to its crucial role in improving patient outcomes and boosting the efficacy of cardiac treatments, the cardiovascular segment keeps leading the global market.
Due to various healthcare environments and economic considerations, the global market shows notable geographical variances. Due to its sophisticated healthcare system, significant expenditures on research and development, and rapidly aging population, North America commands the majority of the global market. The United States significantly influences the demand for biomaterials.
Following closely is Europe, which benefits from a developed healthcare system and the rising demand for biomaterials in medical treatments. The region's two main markets are Germany and the United Kingdom.
Asia Pacific is expanding quickly, propelled by rising healthcare costs, a booming middle class, and growing knowledge of biomaterial applications. India and China are becoming significant biomaterial manufacturers in the area.
| Region | North America |
|---|---|
| Market Share | 28.5% |
| F-CAGR | 5.8% |
| Region | Latin America |
|---|---|
| Market Share | 5.1% |
| F-CAGR | 5.2% |
| Region | East Asia |
|---|---|
| Market Share | 14.0% |
| F-CAGR | 13.4% |
| Region | South Asia Pacific |
|---|---|
| Market Share | 15.6% |
| F-CAGR | 14.8% |
| Region | Western Europe |
|---|---|
| Market Share | 19.2% |
| F-CAGR | 7.0% |
| Region | Eastern Europe |
|---|---|
| Market Share | 7.1% |
| F-CAGR | 5.6% |
| Region | Middle East & Africa |
|---|---|
| Market Share | 10.5% |
| F-CAGR | 5.7% |
An untapped opportunity exists in the Middle East, Africa, and Latin America, with an increasing emphasis on expanding infrastructure and healthcare access. More biomaterials are expected to be used as healthcare systems develop in these regions.
While Latin America, the Middle East, and Africa promise future global Biomaterial Market growth, it exhibits regional diversification, with North America, Europe, and Asia Pacific topping.
| The United States | 6.0% |
|---|---|
| China | 13.3% |
| The United Kingdom | 5.5% |
| Germany | 6.1% |
| India | 15% |
The development and production of materials intended for medical and healthcare applications characterize the burgeoning biomaterials business in the United States. These biomaterials, polymers, ceramics, metals, or composites are essential for many medical devices, tissue engineering, and regenerative medicine biomaterials. Aging populations, rising healthcare costs, and advances in biotechnology are some drivers propelling the medical biomaterials industry.
The biomaterial manufacturers and medical device manufacturers are essential players. The Biomaterial Market in the United States is positioned for continuing growth and technical breakthroughs thanks to ongoing research and innovation.
The Germany Biomaterial Market focuses on the development and application of materials that interact with biological systems, which is seeing tremendous growth. These materials have several uses in regenerative medicine biomaterials and tissue engineering, biomaterials for medical devices, and drug delivery systems. The market's primary drivers are the aging population, increased healthcare spending, and growing demand for cutting-edge healthcare solutions.
In the medical biomaterials industry, essential biomaterials include composites, metals, ceramics, and polymers. Germany's leadership results from its robust healthcare infrastructure, creative research, and regulatory backing. As technology advances, the German Biomaterial Market is positioned for additional growth and innovation.
The research and implementation of cutting-edge materials in diverse medical and healthcare applications characterize the expansion of the United Kingdom Biomaterial Market. The creation of medical devices, tissue engineering, drug delivery systems, and other things all utilize these biomaterials. The United Kingdom has made significant strides in developing biocompatible materials trends, such as polymers, ceramics, and metals, to enhance patient outcomes and healthcare effectiveness.
The medical biomaterials industry is expanding due to an aging population, rising healthcare costs, and a robust pharmaceutical sector. Regulatory backing and partnerships with academic institutions and business stakeholders still push the United Kingdom biomaterials sector's innovation.
The India Biomaterial Market is expanding quickly due to population aging and healthcare technology developments. Medical implants, tissue engineering, and medication delivery systems frequently use biomaterials. Polymers, ceramics, and metals are in high demand as biocompatible materials trends escalate. The government's programs to support research and development promote market expansion.
The India Biomaterial Market is poised for continuous growth, providing significant potential for producers and investors. This is due to rising chronic diseases, increased knowledge of the advantages of biomaterials in medical applications, and the market's readiness for continued growth.
A considerable amount of market expansion has been taking place in China. In China, tissue engineering, pharmaceuticals, and healthcare are just a few industries that use biomaterials, substances that interact with biological systems. The population is getting older, healthcare costs are rising, and biomaterial technology is advancing, the main factors causing this growth.
The market covers a broad spectrum of materials, including polymers, ceramics, metals, and composites utilized in devices for orthopedic implants, drug delivery systems, and wound care. There are several chances for domestic and foreign businesses eager to take advantage of China's expanding biomaterials sector.
Leading biomaterials manufacturers are pursuing various methods, including contracts, partnerships, and research and development initiatives, to increase the scope of their product line.
The global Biomaterial Market has seen a rise in strategic alliances. Leading biomaterials manufacturers are collaborating to create cutting-edge biomaterial-based implants and combination devices by combining their resources, knowledge, and technological capabilities. These partnerships also seek to boost the uptake of biomaterials. These partnerships enable biomaterials manufacturers to increase the Biomaterial Market revenue share and gain a market competitive advantage.
Noteworthy Advancements
| Company | Details |
|---|---|
| Aspect Biosystems | Aspect Biosystems, a business that produces bioprinted biomaterials, and Novo Nordisk began working together in April 2023 to create bioprinted tissue treatments for diabetes and obesity. |
| EUDRATEC Fasteric | EUDRATEC Fasteric, a platform for oral drug delivery technology used for enteric fortification and fast release in the upper smaller intestine, was formally unveiled by Evonik Industries in March 2022. This development supported Evonik's growth by boosting the biocompatibility, safety, and functionality of implanted products used by medical device clients. |
| GE Healthcare | Medtronic and GE Healthcare cooperated in April 2022 to address the distinct needs and demand for care in ambulatory surgery centers (ASCs) and office-based laboratories. (OBLs). Due to this new relationship, customers have access to a massive selection of products, financial solutions, and first-rate assistance. |
| DuPont Sorona | A new spun yarn line that combines natural fibers with DuPont Sorona staple fibers was released in April 2022, according to a statement from DuPont and JP Modatex India. To make spun yarns appropriate for various uses, including dresses, shirting, pants and skirts, jeans, and jackets, the collection combines linen with partially plant-based Sorona fibers. |
The market is to secure a valuation of USD 1,72,689.3 million in 2023.
The market is estimated to reach USD 3,86,983.6 million by 2033.
Through 2033, the industry is anticipated to expand at an 8.4% CAGR.
From 2018 to 2022, the market recorded a 13.3% HCAGR.
The polymer biomaterials category is set to achieve a market share of 33.5%.
A 21.1% share is expected for the cardiology segment in the market.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Metallic 5.2. Natural 5.3. Ceramics 5.4. Polymers 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Cardiovascular 6.1.1. Sensors 6.1.2. Stents 6.1.3. Guidewires 6.1.4. Implantable Cardiac Defibrillators 6.1.5. Pacemakers 6.1.6. Vascular Grafts 6.1.7. Others 6.2. Ophthalmology 6.2.1. Synthetic Corneas 6.2.2. Intraocular Lens 6.2.3. Contact Lens 6.2.4. Ocular Tissue Replacement 6.2.5. Others 6.3. Dental 6.3.1. Tissue Regeneration Materials 6.3.2. Dental Implants 6.3.3. Bone Grafts & Substitutes 6.3.4. Dental Membranes 6.3.5. Others 6.4. Orthopedic 6.4.1. Joint Replacement 6.4.2. Orthobiologics 6.4.3. Bioresorbable Tissue Fixation Products 6.4.4. Viscosupplementation 6.4.5. Spine 6.5. Wound Healing 6.5.1. Fracture Healing Device 6.5.2. Adhesion Barrier 6.5.3. Skin Substitutes 6.5.4. Internal Tissue Sealant 6.6. Surgical Hemostats 6.6.1. Tissue Engineering 6.6.2. Plastic Surgery 6.6.2.1. Facial Wrinkle Treatment 6.6.2.2. Soft Tissue Fillers 6.6.2.3. Craniofacial Surgery 6.6.2.4. Bioengineered Skins 6.6.2.5. Peripheral Nerve Repair 6.6.2.6. Acellular Dermal Matrices 6.6.3. Neurology 6.6.3.1. Neural Stem Cell Encapsulation 6.6.3.2. Shunting Systems 6.6.3.3. Hydrogel Scaffold for CNS Repair 6.6.3.4. Cortical Neural Prosthetics 6.6.3.5. Others 6.6.4. Others 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Western Europe 7.4. Eastern Europe 7.5. South Asia and Pacific 7.6. East Asia 7.7. Middle East and Africa 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. Medtronic plc 17.2. Evonik Industries AG 17.3. Carpenter Technology Corporation 17.4. Berkeley Advanced 17.5. Invibio Ltd. 17.6. Zimmer Biomet Holdings, Inc. 17.7. BASF SE 17.8. Covalon Technologies Ltd. 17.9. Stryker 17.10. Johnson & Johnson 17.11. Dentsply Sirona 17.12. CoorsTek Inc. 17.13. Corbion 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Biomaterial Market
